Testavan 20mg/g transdermal gel refill
BNF presentation 0604020K0BQABBU within chapter Endocrine System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0604020K0BQABBU
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
57
NHS spend (£)
£1,580.38
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 22 |
| December 2024 | 1 |
| November 2024 | 9 |
| October 2024 | 15 |
| August 2024 | 2 |
| July 2024 | 6 |
| May 2024 | 2 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 4 | No data available |
| Unknown pharmacy | 3 | No data available |
| Unknown pharmacy | 3 | No data available |
|
Jenner Healthcare
ODS D81022
|
3 | 06H - CAMBRIDGESHIRE & PETERBOROUGH ICB |
|
Holderness Health
ODS B81025
|
2 | 02Y - HUMBER AND NORTH YORKSHIRE ICB |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
| Unknown pharmacy | 2 | No data available |
|
Rothschild House Group
ODS E82001
|
2 | 06N - HERTFORDSHIRE AND WEST ESSEX ICB |